Skip to main navigation Skip to search Skip to main content

Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits

  • ICBP Consortium
  • , CHARGE consortium
  • , Million Veteran Program
  • , Lifelines Cohort Study
  • National Institutes of Health
  • Vanderbilt University
  • University of Groningen
  • Isfahan University of Medical Sciences
  • Imperial College London
  • University of Ioannina
  • Foundation for Research and Technology-Hellas
  • University of Queensland
  • Queen Mary University of London
  • Barts Health NHS Trust
  • University of Oxford
  • Broad Institute
  • Brigham and Women’s Hospital
  • Harvard University
  • University of Manchester
  • National Heart Lung and Blood Institute’s and Boston University’s Framingham Heart Study
  • Boston University
  • Population Health Research Institute, Ontario
  • University of Newcastle
  • University of Texas Health Science Center at Houston
  • Icahn School of Medicine at Mount Sinai
  • University of Copenhagen
  • National Institute for Health and Welfare
  • Medical University of Graz
  • EURAC Research
  • University of Lübeck
  • University of Leicester
  • National Institute for Health and Care Research
  • Private University of the Principality of Liechtenstein
  • Dr. Risch Anstalt
  • Uppsala University
  • Lund University
  • University of Edinburgh
  • University of Virginia
  • University of Washington
  • The Lundquist Institute
  • University of Lausanne
  • University of New South Wales
  • University of Cambridge
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin
  • University Hospitals of Leicester NHS Trust
  • University of Helsinki
  • King Abdulaziz University
  • Vrije Universiteit Amsterdam
  • Swiss Institute of Bioinformatics
  • University of Trieste
  • IRCCS Ospedale Infantile Burlo Garofolo - Trieste
  • Leiden University
  • Interuniversity Cardiology Institute of the Netherlands
  • Utrecht University
  • Manchester University NHS Foundation Trust
  • University of Michigan, Ann Arbor
  • Newcastle University
  • University of Oulu
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Ludwig Maximilian University of Munich
  • National Research Council of Italy
  • Busselton Population Medical Research Institute
  • University of Western Australia
  • University of Split
  • Algebra University
  • German Centre for Cardiovascular Research
  • St. George's University of London
  • University of Tartu
  • University of Greifswald
  • Icelandic Heart Association
  • University of Iceland
  • University of Liverpool
  • IRCCS Istituto Neurologico Mediterraneo Neuromed - Pozzilli (IS)
  • Baylor College of Medicine
  • San Raffaele Scientific Institute
  • Fimlab Laboratories
  • Tampere University
  • University of Turku
  • Massachusetts General Hospital
  • University of Glasgow
  • Lee Kong Chian School of Medicine
  • Hospital del Mar
  • CIBER de Enfermedades Cardiovasculares
  • The University of Vic - Central University of Catalonia
  • New York Academy of Medicine
  • University of Tartu
  • Health Data Research UK
  • Karolinska Institutet
  • University of Eastern Finland
  • Amsterdam UMC
  • University of Dundee
  • Technical University of Munich
  • University of Cambridge
  • King's College London
  • DataTecnica LLC
  • Duke University
  • Wellcome Trust Sanger Institute
  • Department of Twin Research and Genetic Epidemiology
  • Emory University
  • VA Atlanta Healthcare System
  • Department of Veterans Affairs

Research output: Contribution to journalArticlepeer-review

Abstract

Hypertension affects more than one billion people worldwide. Here we identify 113 novel loci, reporting a total of 2,103 independent genetic signals (P < 5 × 10−8) from the largest single-stage blood pressure (BP) genome-wide association study to date (n = 1,028,980 European individuals). These associations explain more than 60% of single nucleotide polymorphism-based BP heritability. Comparing top versus bottom deciles of polygenic risk scores (PRSs) reveals clinically meaningful differences in BP (16.9 mmHg systolic BP, 95% CI, 15.5–18.2 mmHg, P = 2.22 × 10−126) and more than a sevenfold higher odds of hypertension risk (odds ratio, 7.33; 95% CI, 5.54–9.70; P = 4.13 × 10−44) in an independent dataset. Adding PRS into hypertension-prediction models increased the area under the receiver operating characteristic curve (AUROC) from 0.791 (95% CI, 0.781–0.801) to 0.826 (95% CI, 0.817–0.836, ∆AUROC, 0.035, P = 1.98 × 10−34). We compare the 2,103 loci results in non-European ancestries and show significant PRS associations in a large African-American sample. Secondary analyses implicate 500 genes previously unreported for BP. Our study highlights the role of increasingly large genomic studies for precision health research.

Original languageEnglish
Pages (from-to)778-791
Number of pages14
JournalNature Genetics
Volume56
Issue number5
Early online dateApr 2024
DOIs
Publication statusPublished - May 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits'. Together they form a unique fingerprint.

Cite this